LT - Bispecifinės antigenus surišančios molekulės, kurios suriša CD3 ir CD20, ir jų panaudojimas
EN - BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND CD3 AND CD20, AND USES THEREOF
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07K 16/28 |
(2006.01) |
|
|
A61K 39/00 |
(2006.01) |
|
|
A61K 39/395 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
|
|
A61P 35/02 |
(2006.01) |
|
|
A61P 37/04 |
(2006.01) |
European patent
| (11) |
Number of the document |
3778641 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
20186993.0 |
|
Date of filing the European patent application |
2013-09-19 |
| (97) |
Date of publication of the European application |
2021-02-17 |
| (45) |
Date of publication and mention of the grant of the patent |
2023-11-08
|
| (46) |
Date of publication of the claims translation |
2023-12-11
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
201261704029 P |
2012-09-21
|
US |
|
201361753461 P |
2013-01-17
|
US |
|
201361763110 P |
2013-02-11
|
US |
|
201361827098 P |
2013-05-24
|
US |
Inventors
| (72) |
SMITH, Eric , US
PAPADOPOULOS, Nicholas J , US
|
Grantee
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
Bispecifinės antigenus surišančios molekulės, kurios suriša CD3 ir CD20, ir jų panaudojimas |
| |
BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND CD3 AND CD20, AND USES THEREOF |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-08-20 |
13 |
289.00
EUR
|
Next renewal fee
|
2026-09-19 |
